New developments in FcepsilonRI regulation, function and inhibition - PubMed
Review
New developments in FcepsilonRI regulation, function and inhibition
Stefan Kraft et al. Nat Rev Immunol. 2007 May.
Abstract
The high-affinity Fc receptor for IgE (FcepsilonRI), a multimeric immune receptor, is a crucial structure for IgE-mediated allergic reactions. In recent years, advances have been made in several important areas of the study of FcepsilonRI. The first area relates to FcepsilonRI-mediated biological responses that are antigen independent. The second area encompasses the biological relevance of the distinct signalling pathways that are activated by FcepsilonRI; and the third area relates to the accumulated evidence for the tight control of FcepsilonRI signalling through a broad array of inhibitory mechanisms, which are being developed into promising therapeutic approaches.
Similar articles
-
Regulation of allergy by Fc receptors.
Bruhns P, Frémont S, Daëron M. Bruhns P, et al. Curr Opin Immunol. 2005 Dec;17(6):662-9. doi: 10.1016/j.coi.2005.09.012. Epub 2005 Oct 7. Curr Opin Immunol. 2005. PMID: 16214316 Review.
-
Fc receptors as determinants of allergic reactions.
Kraft S, Novak N. Kraft S, et al. Trends Immunol. 2006 Feb;27(2):88-95. doi: 10.1016/j.it.2005.11.008. Epub 2005 Dec 1. Trends Immunol. 2006. PMID: 16324885 Review.
-
The role of the FcepsilonRI beta-chain in allergic diseases.
Kraft S, Rana S, Jouvin MH, Kinet JP. Kraft S, et al. Int Arch Allergy Immunol. 2004 Sep;135(1):62-72. doi: 10.1159/000080231. Epub 2004 Aug 13. Int Arch Allergy Immunol. 2004. PMID: 15316148 Review.
-
FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R, Soheili ZS, Deezagi A, Pourpak Z, Samiei S, Moin M. Safaralizadeh R, et al. Iran J Allergy Asthma Immunol. 2009 Dec;8(4):177-83. Iran J Allergy Asthma Immunol. 2009. PMID: 20404387
-
[Progress in the study of allergic disease drugs targeting on IgE/FcepsilonRI signaling pathway].
Liu ZC, Shi HL, Zhang YF, Zhao LJ. Liu ZC, et al. Yao Xue Xue Bao. 2011 Oct;46(10):1161-6. Yao Xue Xue Bao. 2011. PMID: 22242444 Review. Chinese.
Cited by
-
A Comparison of Natural and Therapeutic Anti-IgE Antibodies.
Vogel M, Engeroff P. Vogel M, et al. Antibodies (Basel). 2024 Jul 16;13(3):58. doi: 10.3390/antib13030058. Antibodies (Basel). 2024. PMID: 39051334 Free PMC article. Review.
-
Argueta DA, Tran H, Goel Y, Nguyen A, Nguyen J, Kiven SB, Chen C, Abdulla F, Vercellotti GM, Belcher JD, Gupta K. Argueta DA, et al. Life Sci Alliance. 2024 Sep 6;7(11):e202402788. doi: 10.26508/lsa.202402788. Print 2024 Nov. Life Sci Alliance. 2024. PMID: 39242155 Free PMC article.
-
An SB, Yang BG, Jang G, Kim DY, Kim J, Oh SM, Oh N, Lee S, Moon JY, Kim JA, Kim JH, Song YJ, Hyun HW, Kim J, Lee K, Lee D, Kwak MJ, Kim BK, Park YK, Hong CP, Kim JH, Lim HS, Ryu MS, Jin HT, Lee SW, Chang YS, Park HS, Sung YC, Jang MH. An SB, et al. Nat Commun. 2022 Sep 27;13(1):5669. doi: 10.1038/s41467-022-33176-1. Nat Commun. 2022. PMID: 36167830 Free PMC article.
-
Quantitative nanoscale analysis of IgE-FcεRI clustering and coupling to early signaling proteins.
Veatch SL, Chiang EN, Sengupta P, Holowka DA, Baird BA. Veatch SL, et al. J Phys Chem B. 2012 Jun 14;116(23):6923-35. doi: 10.1021/jp300197p. Epub 2012 Apr 2. J Phys Chem B. 2012. PMID: 22397623 Free PMC article.
-
Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM. Anania JC, et al. Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018. Front Immunol. 2018. PMID: 30177930 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical